Business & Finance
Thu, March 8, 2012 
PURCHASE, N.Y.--([ BUSINESS WIRE ])--MVC Capital, Inc. (NYSE: MVC) (the "Fund"), a publicly traded business development company that makes private debt and equity investments, today announced that the Board of Directors of Summit Research Labs, Inc. ("Summit"), an MVC portfolio company, approved a recapitalization, resulting in a $12 million dividend to be paid to the Fund as of March 7, 2012. This provides the Fund with operating income of approximately $0.50 per share.
"We are proud that we have been able to help Summit grow over time, allowing for this recapitalization to occur and for the Fund's shareholders to benefit from the strength of our portfolio."
With the receipt of this $12 million distribution, and taking into account the first quarter of 2012 total operating income of $3.6 million, the Fund has already earned over 97% of fiscal 2011 total operating income within the first five months of fiscal 2012.
"We are delighted that Summit's financial health can support such a large distribution," said Michael Tokarz, Chairman and Portfolio Manager of MVC. "We are proud that we have been able to help Summit grow over time, allowing for this recapitalization to occur and for the Fund's shareholders to benefit from the strength of our portfolio."
MVC-G
About MVC Capital, Inc.
MVC is a business development company traded on the New York Stock Exchange that provides long-term debt and equity investment capital to fund growth, acquisitions and recapitalizations of companies in a variety of industries. For additional information about MVC, please visit the MVC's website at [ www.mvccapital.com ]. For MVC's investor relations, please call 914-510-9400. All media inquiries should be directed to Nathaniel Garnick at 212-687-8080.
Forward-Looking Statements
The information contained in this press release contains forward-looking statements. These forward-looking statements are subject to the inherent uncertainties in predicting future results and conditions. Certain factors could cause actual results and conditions to differ materially from those projected in these forward-looking statements, and these factors are enumerated in the company's periodic filings with the Securities and Exchange Commission.
